Sameek Roychowdhury
Dr. Roychowdhury works to underline and identify genetic alterations, which is a major step forward in personalizing cancer treatments. This work will provide a greater understanding of the totality of...Read More
Sumit Subudhi
Ipilimumab is a cancer immunotherapy that has recently been FDA approved for treatment of metastatic melanoma. A phase 3 clinical trial in metastatic prostate cancer patients failed to demonstrate an...Read More
Dana Rathkopf
The success of next-generation androgen receptor (AR) inhibitors for treatment of castration-resistant prostate cancer validates the critical role played by AR in advanced disease. Unfortunately, patients develop resistance to AR-targeted...Read More
Tanya Stoyanova
Few options remain for prostate cancer patients who have failed to respond to androgen deprivation therapy. New therapeutic targets and treatments are desperately needed. Dr. Tanya Stoyanova is investigating two...Read More
Jennifer Doll, PhD
Periprostatic Fat as a Promoter of Prostate Cancer Progression Obesity and high fat diets are associated with more aggressive prostate cancer. Yet, the mechanism underlying this association remains unclear. Dr....Read More
Antoinette Perry
A critical unmet need for prostate cancer research is the identification of aggressive tumors at an early stage while potentially curable and distinguishing them from indolent tumors to avoid over-treatment...Read More
Brendan Curti, MD
Augmenting OX40 Immunotherapy in Men with Advanced Prostate Cancer Dr. Curti and his team are pioneers in the preclinical and clinical development of a new immunotherapy that activates the anti-tumor...Read More
Matthias Stephan
The immune system is a powerful natural defense system that targets and kills cells considered by the host to be dangerous. Tumors survive because of their ability to evade or...Read More
Kathryn L. Penney
The Gleason score (derived from the microscopic appearance of prostate tumor tissue) is currently the only reliable predictor for prostate cancer prognosis and treatment. Dr. Penney has previously identified a...Read More
Tamara Lotan, MD
Dr. Tamara Lotan is an associate professor of pathology and oncology at the Johns Hopkins University School of Medicine. Her area of clinical expertise is urologic pathology. Dr. Lotan received...Read More